182 related articles for article (PubMed ID: 10570051)
41. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
42. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
[TBL] [Abstract][Full Text] [Related]
43. Models of drug interaction with the sodium channel.
Grant AO
Clin Invest Med; 1991 Oct; 14(5):447-57. PubMed ID: 1660367
[TBL] [Abstract][Full Text] [Related]
44. Sodium channel molecular conformations and antiarrhythmic drug affinity.
Sheets MF; Fozzard HA; Lipkind GM; Hanck DA
Trends Cardiovasc Med; 2010 Jan; 20(1):16-21. PubMed ID: 20685573
[TBL] [Abstract][Full Text] [Related]
45. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels.
Franchini C; Carocci A; Catalano A; Cavalluzzi MM; Corbo F; Lentini G; Scilimati A; Tortorella P; Camerino DC; De Luca A
J Med Chem; 2003 Nov; 46(24):5238-48. PubMed ID: 14613326
[TBL] [Abstract][Full Text] [Related]
46. Sodium channel selectivity filter regulates antiarrhythmic drug binding.
Sunami A; Dudley SC; Fozzard HA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14126-31. PubMed ID: 9391164
[TBL] [Abstract][Full Text] [Related]
47. Cardiac-specific external paths for lidocaine, defined by isoform-specific residues, accelerate recovery from use-dependent block.
Lee PJ; Sunami A; Fozzard HA
Circ Res; 2001 Nov; 89(11):1014-21. PubMed ID: 11717158
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker.
Walker MJA; Hayes ES; Saint DA; Adaikan G; Abraham S; Goldin AL; Beatch GN; MacLeod BA; Wall RA; Pugsley MK
Biomed Pharmacother; 2018 Oct; 106():510-522. PubMed ID: 29990839
[TBL] [Abstract][Full Text] [Related]
49. Hydroxylated analogs of mexiletine as tools for structural-requirements investigation of the sodium channel blocking activity.
Catalano A; Carocci A; Cavalluzzi MM; Di Mola A; Lentini G; Lovece A; Dipalma A; Costanza T; Desaphy JF; Conte Camerino D; Franchini C
Arch Pharm (Weinheim); 2010 Jun; 343(6):325-32. PubMed ID: 20509146
[TBL] [Abstract][Full Text] [Related]
50. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury.
Hewitt KE; Stys PK; Lesiuk HJ
Brain Res; 2001 Apr; 898(2):281-7. PubMed ID: 11306014
[TBL] [Abstract][Full Text] [Related]
51. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
52. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
[TBL] [Abstract][Full Text] [Related]
53. State-dependent block of human cardiac hNav1.5 sodium channels by propafenone.
Edrich T; Wang SY; Wang GK
J Membr Biol; 2005 Sep; 207(1):35-43. PubMed ID: 16463141
[TBL] [Abstract][Full Text] [Related]
54. Point mutations at the local anesthetic receptor site modulate the state-dependent block of rat Na v1.4 sodium channels by pyrazoline-type insecticides.
Silver KS; Soderlund DM
Neurotoxicology; 2007 May; 28(3):655-63. PubMed ID: 17367864
[TBL] [Abstract][Full Text] [Related]
55. Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.
Zhao J; Duprè N; Puymirat J; Chahine M
J Physiol; 2012 Jun; 590(11):2629-44. PubMed ID: 22250216
[TBL] [Abstract][Full Text] [Related]
56. A multifunctional aromatic residue in the external pore vestibule of Na+ channels contributes to the local anesthetic receptor.
Tsang SY; Tsushima RG; Tomaselli GF; Li RA; Backx PH
Mol Pharmacol; 2005 Feb; 67(2):424-34. PubMed ID: 15659774
[TBL] [Abstract][Full Text] [Related]
57. Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
Desaphy JF; Carbonara R; Costanza T; Lentini G; Cavalluzzi MM; Bruno C; Franchini C; Camerino DC
Mol Pharmacol; 2013 Feb; 83(2):406-15. PubMed ID: 23175529
[TBL] [Abstract][Full Text] [Related]
58. Use-dependent block of Na+ currents by mexiletine at the single channel level in guinea-pig ventricular myocytes.
Sunami A; Fan Z; Sawanobori T; Hiraoka M
Br J Pharmacol; 1993 Sep; 110(1):183-92. PubMed ID: 8220878
[TBL] [Abstract][Full Text] [Related]
59. Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation.
Zhu W; Mazzanti A; Voelker TL; Hou P; Moreno JD; Angsutararux P; Naegle KM; Priori SG; Silva JR
Circ Res; 2019 Feb; 124(4):539-552. PubMed ID: 30566038
[TBL] [Abstract][Full Text] [Related]
60. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
